Lessons and limits of mouse models

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 12, 2013, Pages

  Chong, Anita S ^a   Alegre, Maria Luisa ^a   Miller, Michelle L ^a   Fairchild, Robert L ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNITY; ANTIBODY MEDIATED REJECTION; ARTICLE; GRAFT REJECTION; HEART TRANSPLANTATION; HYPERACUTE GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOBIOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE MODEL; NONHUMAN; SKIN TRANSPLANTATION; TRANSPLANTATION TOLERANCE; ANIMAL; B LYMPHOCYTE; DISEASE MODEL; HISTOCOMPATIBILITY; IMMUNOLOGY; MOUSE; PHYSIOLOGY; RABBIT; REVIEW; T LYMPHOCYTE;

ANTIBODY;

ANIMALS; ANTIBODIES; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GRAFT REJECTION; HEART TRANSPLANTATION; KIDNEY TRANSPLANTATION; MICE; RABBITS; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION IMMUNOLOGY;

EID: 84889039328     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a015495     Document Type: Article

References (108)

1. Adams AB, Shirasugi N, Jones TR, Durham MM, Strobert EA, Cowan S, Rees P, Hendrix R, Price K, Kenyon NS, et al. 2005. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J Immunol 174: 542-550.
2. Akiyoshi T, Hirohashi T, Alessandrini A, Chase CM, Farkash EA, Neal Smith R, Madsen JC, Russell PS, Colvin RB. 2012. Role of complement and NK cells in antibody mediated rejection. Hum Immunol 73: 1226-1232.
3. Alegre ML, Fallarino F. 2006. Mechanisms of CTLA-4Ig in tolerance induction. Curr Pharm Des 12: 149-160.
4. Alegre ML, Frauwirth KA, Thompson CB. 2001. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 1: 220-228.
5. Aoyagi T, Yamashita K, Suzuki T, Uno M, Goto R, Taniguchi M, Miura T, Okimura K, Itoh T, Shimizu A, et al. 2009. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: Induction and maintenance therapy. Am J Transplant 9: 1732-1741.
6. Atkinson C, Horsley J, Rhind-Tutt S, Charman S, Phillpotts CJ, Wallwork J, Goddard MJ. 2004. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin. J Heart Lung Transplant 23: 427-435.
7. Atz ME, Reed EF. 2008. Role of anti-MHC class I antibody in facilitating transplant accommodation. Critical Rev Immunol 28: 485-511.
8. Bach FH, Turman MA, Vercellotti GM, Platt JL, Dalmasso AP. 1991. Accommodation: Aworking paradigm for progressing toward clinical discordant xenografting. Transplant Proc 23: 205-207.
9. Bach FH, Ferran C, Hechenleitner P, Mark W, Koyamada N, Miyatake T, Winkler H, Badrichani A, Candinas D, Hancock WW. 1997. Accommodation of vascularized xenografts: Expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3: 196-204.
10. Badell IR, Russell MC, Thompson PW, Turner AP, Weaver TA, Robertson JM, Avila JG, Cano JA, Johnson BE, Song M, et al. 2010. LFA-1-specific therapy prolongs allograft survival in rhesus macaques. J Clin Invest 120: 4520-4531.
11. Badell IR, Thompson PW, Turner AP, Russell MC, Avila JG, Cano JA, Robertson JM, Leopardi FV, Strobert EA, Iwakoshi NN, et al. 2012. Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates. Am J Transplant 12: 126-135.
12. Baldwin WM III, Valujskikh A, Fairchild RL. 2010. Antibody-mediated rejection: Emergence of animal models to answer clinical questions. Am J Transplant 10: 1135-1142.
13. Bergstresser PR, Toews GB, Gilliam JN, Streilein JW. 1980a. Unusual numbers and distributions of Langerhans cells in skin with unique immunologic properties. J Invest Dermatol 74: 312-314.
14. Bergstresser PR, Fletcher CR, Streilein JW. 1980b. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties. J Invest Dermatol 74: 77-80.
15. Bickerstaff AA, Wang JJ, Pelletier RP, Orosz CG. 2001. Murine renal allografts: Spontaneous acceptance is associated with regulated T cell-mediated immunity. J Immunol 167: 4821-4827.
16. 2/ 2 recipients. Am J Transplant 8: 557-566.
17. Billingham RE, Medawar PB. 1951. Technique of free skin grafting in mammals. J Exp Biol 28: 385-391.
18. Bobadilla JL, Love RB, Jankowska-Gan E, Xu Q, Haynes LD, Braun RK, Hayney MS, Munoz del Rio A, Meyer K, Greenspan DS, et al. 2008. Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med 177: 660-668.
19. Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, Bobadilla JL, Meyer KC, Hayney MS, Braun RK, Greenspan DS, et al. 2007. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 117: 3498-3506.
20. Burns AM, Chong AS. 2011. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming. J Immunol 186: 214-221.
21. Calcagni M, Althaus MK, Knapik AD, Hegland N, Contaldo C, Giovanoli P, Lindenblatt N. 2011. In vivo visualization of the origination of skin graft vasculature in a wild-type/ GFP crossover model. Microvasc Res 82: 237-245.
22. Capla JM, Ceradini DJ, Tepper OM, Callaghan MJ, Bhatt KA, Galiano RD, Levine JP, Gurtner GC. 2006. Skin graft vascularization involves precisely regulated regression and replacement of endothelial cells through both angiogenesis and vasculogenesis. Plast Reconstr Surg 117: 836-844.
23. Charbonnier LM, Vokaer B, Lemaître PH, Field KA, Leo O, Le Moine A. 2012. CTLA-4Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells. Am J Transplant 12: 2313-2321.
24. Chen H-D, Silvers WK. 1983. Influence of Langerhans cells on the survial of H-Y incompatible skin grafts in rats. J Invest Dermatol 81: 20-23.
25. Cook CH, Bickerstaff AA, Wang J-J, Nadasdy T, Della Pelle P, Colvin RB, Orosz CG. 2008. Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO. J Immunol 180: 3103-3112.
26. Corry RJ, Winn HJ, Russell PS. 1973. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16: 343-350.
27. Curry AJ, Chikwe J, Smith XG, Cai M, Schwarz H, Bradley JA, Bolton EM. 2004. OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival. Transplantation 78: 807-814.
28. {thorn} T lymphocytes. J Immunol 148: 1985-1989.
29. Denecke C, Yuan X, Ge X, Kim IK, Bedi D, Boenisch O, Weiland A, Jurisch A, Kotsch K, Pratschke J, et al. 2013. Synergistic effects of prolonged warm ischemia and donor age on the immune response following donation after cardiac death kidney transplantation. Surgery 153: 249-261.
30. Ding JW, Zhou T, Zeng H, Ma L, Verbeek JS, Yin D, Shen J, Chong AS. 2008a. Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-g receptors. J Immunol 180: 261-268.
31. Ding JW, Zhou T, Ma L, Yin D, Shen J, Ding CP, Tang IY, Byrne GW, Chong AS. 2008b. Expression of complement regulatory proteins in accommodated xenografts induced by anti-a-Gal IgG1 in a rat-to-mouse model. Am J Transplant 8: 32-40.
32. Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, Chalasani G, Sayegh MH, Najafian N, Rothstein DM. 2011. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 121: 3645-3656.
33. Emtiazjoo AM, Wilkes DS. 2013. Humoral immunity and the development of obliterative bronchiolitis post lung transplantation-Is there a link? Am J Respir Cell Mol Biol 48: 145-149.
34. Fukami N, Ramachandran S, Saini D, Walter M, Chapman W, Patterson GA, Mohanakumar T. 2009. Antibodies to MHC class I induce autoimmunity: Role in the pathogenesis of chronic rejection. J Immunol 182: 309-318.
35. Fukami N, Ramachandran S, Takenaka M, Weber J, Subramanian V, Mohanakumar T. 2012a. An obligatory role for lung infiltrating B cells in the immunopathogenesis of obliterative airway disease induced by antibodies to MHC class I molecules. Am J Transplant 12: 867-876.
36. Fukami N, Ramachandran S, Narayanan K, Liu W, Nath DS, Jendrisak M, Chapman W, Mohanakumar T. 2012b. Mechanism of accommodation in a sensitized human leukocyte antigen transgenic murine cardiac transplant model. Transplantation 93: 364-372.
37. Ge F, Gong W. 2011. Strategies for successfully establishing a kidney transplant in a mouse model. Exp Clin Transplant 9: 287-294.
38. Gibson T, Medawar PB. 1943. The fate of skin homografts in man. J Anat 77: 299-316.
39. Hagensen MK, Shim J, Falk E, Bentzon JF. 2011. Flanking recipient vasculature, not circulating progenitor cells, contributes to endothelium and smooth muscle in murine allograft vasculopathy. Arterioscler Thromb Vasc Biol 31: 808-813.
40. Hattori Y, Bucy RP, Kubota Y, Baldwin WM III, Fairchild RL. 2012. Antibody-mediated rejection of single class I MHC-disparate cardiac allografts. Am J Transplant 12: 2017-2028.
41. He C, Schenk S, Zhang Q, Valujskikh A, Bayer J, Fairchild RL, Heeger PS. 2004. Effects of T cell frequency and graft size on transplant outcome in mice. J Immunol 172: 240-247.
42. Iwasaki K, Miwa Y, Ogawa H, Yazaki S, Iwamoto M, Furusawa T, Onishi A, Kuzuya T, Haneda M, Watarai Y, et al. 2012. Comparative study on signal transduction in endothelial cells after anti-a/b and human leukocyte antigen antibody reaction: Implication of accommodation. Transplantation 93: 390-397.
43. Kaufman CL, Colson YL, Wren SM, Watkins S, Simmons RL, Ildstad ST. 1994. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84: 2436-2446.
44. Kawai T, Cosimi AB, Colvin RB, Powelson J, Eason J, Kozlowski T, Sykes M, Monroy R, Tanaka M, Sachs DH. 1995. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59: 256-562.
45. Koene RA, Gerlag PG, Hagemann JF, van Haelst UJ, Wijdeveld PG. 1973. Hyperacute rejection of skin allografts in the mouse by the administration of alloantibody and rabbit complement. J Immunol 111: 520-526.
46. Koyama I, Kawai T, Andrews D, Boskovic S, Nadazdin O, Wee SL, Sogawa H, Wu DL, Smith RN, Colvin RB, et al. 2004. Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation 77: 460-462.
47. Krasinskas AM, Eiref SD, McLean AD, Kreisel D, Gelman AE, Popma SH, Moore JS, Rosengard BR. 2000. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection. Transplantation 70: 514-521.
48. Kwun J, Malarkannnan S, Burlingham WJ, Knechtle SJ. 2011. Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation. J Immunol 187: 3997-4006.
49. Kwun J, Oh BC, Gibby AC, Ruhil R, Lu VT, Kim DW, Page EK, Bulut OP, Song MQ, Farris AB, et al. 2012. Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment. Am J Transplant 12: 2641-2651.
50. bm12. Transplantation 31: 434-438.
51. Larsen CP, Page A, Linzie KH, Russell M, Deane T, Stempora L, Strobert E, Penedo MC, Ward T, Wiseman R, et al. 2010. An MHC-defined primate model reveals significant rejection of bone marrow after mixed chimerism induction despite full MHC matching. Am J Transplant 10: 2396-2409.
52. Lee KM, Kim JI, Stott R, Soohoo J, O'Connor MR, Yeh H, Zhao G, Eliades P, Fox C, Cheng N, et al. 2012. Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells. Am J Transplant 12: 2072-2078.
53. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA. 1992. Longterm survival of xenogeneic pancreatic islet grafts induced by CTLA-4Ig. Science 257: 789-792.
54. Li W, Lu L, Wang Z, Wang L, Fung JJ, Thomson AW, Qian S. 2001. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. Transplantation 72: 1423-1432.
55. Li W, Zheng XX, Kuhr CS, Perkins JD. 2005. CTLA-4 engagement is required for induction of murine liver transplant spontaneous tolerance. Am J Transplant 5: 978-986.
56. {thorn} regulatory T cells. Am J Transplant 8: 1639-1651.
57. Li Q, Peng Q, Xing G, Li K, Wang N, Farrar CA, Meader L, Sacks SH, Zhou W. 2010. Deficiency of C5aR prolongs renal allograft survival. J Am Soc Nephrol 21: 1344-1353.
58. Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA. 1993. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA-4Ig plus donor-specific transfusion. J Exp Med 178: 1801-1806.
59. Lindenblatt N, Calcagni M, Contaldo C, Menger MD, Giovanoli P, Vollmar B. 2008. A new model for studying the revascularization of skin grafts in vivo: The role of angiogenesis. Plast Reconstr Surg 122: 1669-1680.
60. Lu WH, Palatnik K, Fishbein GA, Lai C, Levi DS, Perens G, Alejos J, Kobashigawa J, Fishbein MC. 2011. Diverse morphologic manifestations of cardiac allograft vasculopathy: A pathologic study of 64 allograft hearts. J Heart Lung Transplant 30: 1044-1050.
61. Ma L-L, Gao X, Liu L, Xiang Z, Blackwell TS, Williams P, Chari RS, Yin DP. 2009. CpG oligodeoxynucleotide triggers the liver inflammatory reaction and abrogates spontaneous tolerance. Liver Transpl 15: 915-923.
62. Manilay JO, Pearson DA, Sergio JJ, Swenson KG, Sykes M. 1998. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation 66: 96-102.
63. McFarland HI, Rosenberg AS. 2009. Skin allograft rejection. Curr Protoc Immunol 4: 4.
64. bm12, a new H-2 mutation in the I region in the mouse. J Exp Med 150: 1323-1338.
65. Medawar PB. 1944. The behavior and fate of skin autografts and skin homografts in rabbits. J Anat 78: 176-199.
66. Medawar PB. 1945. A second study of the behaviour and fate of skin homografts in rabbits. J Anat 79: 157-177.
67. Mele TS, Kneteman NM, Zhu L-F, Ramassar V, Urmson J, Halloran B, Churchill TA, Jewell L, Kane K, Halloran PF. 2003. IFN-g is an absolute requirement for spontaneous acceptance of liver allografts. Am J Transplant 3: 942-951.
68. Meng L, Wu Z, Wang Y, Lassman C, Busuttil RW, Zhai Y, Kupiec-Weglinski JW, et al. 2008. Differential impact of CD154 costimulation blockade on alloreactive effector and regulatory T cells in murine renal transplant recipients. Transplantation 85: 1332-1338.
69. Mengel M, Husain S, Hidalgo L, Sis B. 2012. Phenotypes of antibody-mediated rejection in organ transplants. Transpl Int 25: 611-622.
70. Mengle-Gaw L, Conner S, McDevitt HO, Fathman CG. 1984. Gene conversion between murine class II major histocompatibility complex loci: Functional and molecular evidence from the bm12 mutant. J Exp Med 160: 1184-1194.
71. Minami E, Laflamme MA, Saffitz JE, Murry CE. 2005. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 112: 2951-2958.
72. Morgan BP. 1995. Complement regulatory molecules: Application to therapy and transplantation. Immunol Today 16: 257-259.
73. Morita M, Fujino M, Li X-K, Kimura H, Nakayama T, Taniguchi M, Sugioka A. 2007. Spontaneous tolerance involving natural killer T cells after hepatic grafting in mice. Transplant Immunol 18: 142-145.
74. Morita M, Fujino M, Jiang G, Kitazawa Y, Xie L, Azuma M, Yagita H, Nagao S, Sugioka A, Kurosawa Y, et al. 2010. PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft. Am J Transplant 10: 40-46.
75. Ng YH, Oberbarnscheidt MH, Chandramoorthy HC, Hoffman R, Chalasani G. 2010. B cells help alloreactive T cells differentiate into memory T cells. Am J Transplant 10: 1970-1980.
76. Noorchashm H, Reed AJ, Rostami SY, Mozaffari R, Zekavat G, Koeberlein B, Caton AJ, Naji A. 2006. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol 177: 7715-7722.
77. Nozaki T, Amano H, Bickerstaff A, Orosz CG, Novick AC, Tanabe K, Fairchild RL. 2007. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients. J Immunol 179: 5238-5245.
78. Oberhuber R, Ge X, Tullius SG. 2012. Donor age-specific injury and immune responses. Am J Transplant 12: 38-42.
79. Pasquet L, Joffre O, Santolaria T, van Meerwijk JP. 2011. Hematopoietic chimerism and transplantation tolerance: A role for regulatory T cells. Front Immunol 2: 80.
80. Pilat N, Baranyi U, Klaus C, Jaeckel E, Mpofu N, Wrba F, Golshayan D, Muehlbacher F, Wekerle T. 2010. Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning. Am J Transplant 10: 751-762.
81. Pratt JR, Basheer SA, Sacks SH. 2002. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 8: 582-587.
82. Preston EH, Xu H, Dhanireddy KK, Pearl JP, Leopardi FV, Starost MF, Hale DA, Kirk AD. 2005. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. Am J Transplant 5: 1032-1041.
83. Quezada SA, Bennett K, Blazar BR, Rudensky AY, Sakaguchi S, Noelle RJ. 2005. Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: The interplay of clonal anergy and immune regulation. J Immunol 175: 771-779.
84. Rahimi S, Qian Z, Layton J, Fox-Talbot K, Baldwin WM III, Wasowska BA. 2004. Non-complementand complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant 4: 326-334.
85. Reichenbach DK, Li Q, Hoffman RA, Williams AL, Shlomchik WD, Rothstein DM, Demetris AJ, Lakkis FG. 2013. Allograft outcomes in outbred mice. Am J Transplant 13: 580-588.
86. Riella LV, Liu T, Yang J, Chock S, Shimizu T, Mfarrej B, Batal I, Xiao X, Sayegh MH, Chandraker A. 2012. Deleterious effect of CTLA-4Ig on a Treg-dependent transplant model. Am J Transplant 12: 846-855.
87. Russell PS, Chase CM, Colvin RB, Plate JMD. 1978. Kidney transplants in mice: An analysis of the immune status of mice bearing long-ter, H-2 incompatible transplants. J Exp Med 147: 1449-1468.
88. {thorn} T cells. J Immunol 174: 3741-3748.
89. Schenk AD, Nozaki T, Rabant M, Valujskikh A, Fairchild RL. 2008. Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24-h posttransplant in naive recipients. Am J Transplant 8: 1652-1661.
90. Schenk AD, Gorbacheva V, Rabant M, Fairchild RL, Valujskikh A. 2009. Effector functions of donor-reactive CD8 memory T cells are dependent on ICOS induced during division in cardiac grafts. Am J Transplant 9: 64-73.
91. Sharabi Y, Abraham VS, Sykes M, Sachs DH. 1992. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: Requirement for chimerism to maintain tolerance. Bone Marrow Transplant 9: 191-197.
92. Shimizu I, Smith NR, Zhao G, Medof E, Sykes M. 2006. Decay-accelerating factor prevents acute humoral rejection induced by low levels of anti-aGal natural antibodies. Transplantation 81: 95-100.
93. Skoskiewicz M, Chase C, Winn HJ, Russell PS. 1973. Kidney transplants between mice of graded immunogenetic diversity. Transplant Proc 5: 721-725.
94. Smith RN, Colvin RB. 2012. Chronic alloantibody mediated rejection. Semin Immunol 24: 115-121.
95. Soleimani B, Lechler RI, Hornick PI, George AJ. 2006. Role of alloantibodies in the pathogenesis of graft arteriosclerosis in cardiac transplantation. Am J Transplant 6: 1781-1785.
96. Stegall MD, Chedid MF, Cornell LD. 2012. The role of complement in antibody-mediated rejection in kidney transplantation. Nat Rev Nephrol 8: 670-678.
97. Steinmuller D. 1984. Skin grafting. Methods Enzymol 108: 28-35.
98. Suhr BD, Black SM, Guzman-Paz M, Matas AJ, Dalmasso AP. 2007. Inhibition of the membrane attack complex of complement for induction of accommodation in the hamster-to-rat heart transplant model. Xenotransplantation 14: 572-579.
99. Uchiyama H, Kishihara K, Minagawa R, Hashimoto K, Sugimachi K, Nomoto K. 2002. Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice. Immunology 105: 450-457.
100. Valujskikh A, Li XC. 2007. Frontiers in nephrology: T cell memory as a barrier to transplant tolerance. J Am Soc Nephrol 18: 2252-2261.
101. Vu MD, Clarkson MR, Yagita H, Turka LA, Sayegh MH, Li XC. 2006. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol 176: 1394-1401.
102. Wang C, Cordoba S, Hu M, Bertolino P, Bowen DG, Sharland AF, Allen RD, Alexander SI, McCaughan GW, Bishop GA. 2011. Spontaneous acceptance of mouse kidney allografts is associated with increased Foxp3 expression and differences in the B and T cell compartments. Transplant Immunol 24: 149-156.
103. Wasowska BA, Qian Z, Cangello DL, Behrens E, Van Tran K, Layton J, Sanfilippo F, Baldwin WM III. 2001. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Transplantation 71: 727-736.
104. Wehner JR III, Baldwin WM. 2010. Cardiac allograft vasculopathy: Do adipocytes bridge alloimmune and metabolic risk. Curr Opin Organ Transplant 15: 639-644.
105. Wekerle T, Kurtz J, Ito H, Ronquillo JV, Dong V, Zhao G, Shaffer J, Sayegh MH, Sykes M. 2000. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 6: 464-469.
106. Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M. 2002. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 14: 592-600.
107. Wu H, Noordmans GA, O'Brien MR, Ma J, Zhao CY, Zhang GY, Kwan TK, Alexander SI, Chadban SJ. 2012. Absence of MyD88 signaling induces donor-specific kidney allograft tolerance. J Am Soc Nephrol 23: 1701-1716.
108. Yun JJ, Fischbein MP, Whiting D, Irie Y, Fishbein MC, Burdick MD, Belperio J, Strieter RM, Laks H, Berliner JA, et al. 2002. The role of MIG/CXCL9 in cardiac allograft vasculopathy. Am J Pathol 161: 1307-1313.